Fund comparison · from official SEC filings
LABU vs PBE: how much do they overlap?
Direxion Daily S&P Biotech Bull 3X Shares and Invesco Biotechnology & Genome ETF
Holdings overlap17%of assets, by weight Shared positions22of 154 / 33 holdings LABU expense ratio0.93%net, per year PBE expense ratio0.58%net, per year Shared holdings
U
UTHRUNITED THERAPEUTICS CORP
0.92%
5.45%
B
BIIBBIOGEN INC
0.87%
4.38%
I
INCYINCYTE CORP
0.89%
4.26%
A
ALNYALNYLAM PHARMACEUTICALS INC
0.85%
4.20%
R
REGNREGENERON PHARMACEUTICALS
0.80%
4.14%
A
AMGNAMGEN INC
0.81%
4.09%
G
GILDGILEAD SCIENCES INC
0.79%
4.00%
B
BCRXBIOCRYST PHARMACEUTICALS INC
0.63%
2.97%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.11%
2.84%
P
PTGXPROTAGONIST THERAPEUTICS INC
0.90%
2.79%
T
TGTXTG THERAPEUTICS INC
1.06%
2.73%
C
CDNACAREDX INC
0.32%
2.66%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
2.48%
E
EXELEXELIXIS INC
0.94%
2.43%
P
PTCTPTC THERAPEUTICS INC
0.87%
2.32%
V
VCYTVERACYTE INC
0.67%
2.27%
A
ACAACADIA PHARMACEUTICALS INC
0.80%
2.25%
V
VCELVERICEL CORP
0.40%
2.24%
H
HALOHALOZYME THERAPEUTICS INC
0.84%
2.23%
I
IONSIONIS PHARMACEUTICALS INC
0.88%
2.16%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.79%
2.12%
M
MNKDMANNKIND CORP
0.32%
1.26%
Only in LABU
?
—DREYFUS GOVERNMENT CASH MANAGE
7.43%
?
—GOLDMAN SACHS LIQ ES FD A
1.71%
1
1JKAPELLIS PHARMACEUTICALS INC
1.44%
R
RVMDREVOLUTION MEDICINES INC
1.27%
T
TVTXTRAVERE THERAPEUTICS INC
1.25%
T
TWSTTWIST BIOSCIENCE CORP
1.10%
S
SMMTSUMMIT THERAPEUTICS INC
1.09%
A
ALKSALKERMES PLC
1.07%
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.06%
B
BEAMBEAM THERAPEUTICS INC
1.02%
A
APGEAPOGEE THERAPEUTICS INC
0.98%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.95%
P
PRAXPRAXIS PRECISION MEDICINES I
0.95%
M
MIRMMIRUM PHARMACEUTICALS INC
0.93%
N
NTRANATERA INC
0.92%
C
CELCCELCUITY INC
0.92%
C
CRSPCRISPR THERAPEUTICS AG
0.92%
K
KRYSKRYSTAL BIOTECH INC
0.91%
C
CGONCG ONCOLOGY INC
0.89%
C
CYTKCYTOKINETICS INC
0.89%
B
BBIOBRIDGEBIO PHARMA INC
0.88%
P
PCVXVAXCYTE INC
0.88%
Only in PBE
?
—Invesco Private Prime Fund
9.47%
I
ILMNILLUMINA INC
4.66%
?
—Invesco Private Government Fund
3.65%
?
—CATALYST PHARMACEUTICALS, INC.
2.87%
R
RPRXROYALTY PHARMA PLC- CL A
2.72%
T
TECHBIO-TECHNE CORP
2.37%
R
RGENREPLIGEN CORP
2.17%
T
TBPHTHERAVANCE BIOPHARMA INC
2.16%
C
COLLCOLLEGIUM PHARMACEUTICAL INC
1.84%
Q
QGENQIAGEN N.V.
1.76%
A
AGPXXINVESCO GVT & AGNCY-INST
0.05%
Hold LABU and PBE together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.